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Group P1 -adrenergic P2-adrenergic Atrial natriuretic a-myosin
receptor receptor peptide heavy chain
IDC (n = 5) 0.44 ± 0.31 3.29 ± 1.04 23.4 ± 12.4 183 ± 4.61
PPH (n = 3) 0.29 ± 0.08 5.93 ± 1.29 58.2 ± 20.3 10.7 ± 3.44
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1766-31 Fingerprinting Analysis of mRNA from Restenotic
and Primary Atherosclerotic Coronary Plaque
Material Obtained by Atherectomy
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X-Linked Cardiomyopathy: Selective Deficiency of
Dystrophin mRNA and Protein in the Heart
pies are identical. (2) fibronectin levels are increased in R samples, and (3)
the AP-PCR method will be useful to identify novel differentially expressed
gene products. This is the first use of the AP-PCR method to compare gene
expression in restenotic and primary atherosclerotic lesions.
Roger D. Bies. Emma Holder, Masato Maeda Cardiology Division, Temple Hoyne
Buell Laboratories, University of Colorado Health Sciences Center. Denver. CO
Mutations in the membrane associated cytoskeletal protein dystrophin is
typically associated with Duchenne and Beckers Muscular Dystrophy. In-
some cases dystrophin mutations appear causes a selective cardiomyopa-
thy with little skeletal muscle disease. The molecular mechanisms which
cause this phenotype have not been defined. We are particularly interested
in how a mutation in a protein normally expressed in all muscle tissues can
selectively cause disease in the heart. Most cardiomyopathic dystrophin mu-
tations occur at the 5' end of the gene. suggesting that regulatory elements
may playa role in the cardiac specific phenotype. We have analyzed car-
diac and skeletal muscle dystrophin mRNA and protein from a family with
severe cardiomyopathy, and a 5' duplication in exons 2-7 of the dystrophin
gene. Sequence analysis of cDNA across the mutation site, showed no differ-
ence between heart and skeletal muscle transcripts. However, ribonuclease
protection assay demonstrated markedly diminished dystrophin transcript
in the heart. Western blot and immunocytochemistry showed marked re-
duction in cardiac dystrophin protein compared with skeletal muscle. These
results demonstrate that mutations in the 5' dystrophin gene can cause car-
diomyopathy without significant muscle disease by a selective reduction of
dystrophin gene expression in the heart.
Annexins are a unique family of calcium-dependent, phospholipid-binding
proteins found in various tissues. Annexin VI. a major member in the family,
exists in the heart and acts as a potent regulator of the sarcoplasmic reticu-
lum calcium-release channel. cardiac L-type calcium channel and Na+/Ca2+
exchanger. To investigate the role of the regUlation of annexin VI in intra-
cellular calcium homeostasis and mechanical properties of cardiomyocytes.
we used the transgenic mice which overexpresses annexin VI (TG. n = 6)
and control mice (C. n = 6) at three months of age. A 10-fold increase in
annexin VI was revealed by Western blotting in TG mice compared to the
controls. No differences were found between TG and C groups in heart/body
wt., lunglbody wt. or myocyte size.
Cardiomyocytes from TG and C mice were isolated and field paced at 0.25,
0.5 and 1.0 Hz (15,30 and 60 beats per minute). The myocytes of TG mice
demonstrated significant decreases in shortening fraction (% shortening,
TG vs C, 4.59 ± 0.42 vs 8.62 ± 0.85, P < 0.01), rate of shortening (+dl/dt.
j.Lm/sec, TG vs C, 93.54 ± 24.31 vs 148.77 ± 20.23, P < 0.05) and rate of
relengthening (-dl/dt. /<.m/sec, TG vs C, 59.28 ± B.32 vs 119.66 ± 15.94. P <
0.01) at 1.0, but not at 0.25 or 0.5 Hz stimulation. FURA-2 loaded myocytes
from TG mice showed lower baseline levels of calcium at all three stimula-
tion frequencies respectively (340/380 ratio, TG vs C, 0.526 ± 0.075 vs 0.968
± 0.550 at 0.25 Hz, P < 0.001; 0.566 ± 0.044 vs 0.9B2 ± 0.050 at 0.5 Hz, P <
0.001; 0.564 ± 0.043 vs 1.016 ± 0.051 at 1.0 Hz, P < 0.001). The amplitude
of calcium signals decreased in annexin VI TG mice at 0.25 Hz (340/380 ratio.
TG vs C, 0.974 ± 0.14B vs 0.541 ± 0.082, P < 0.05) and at 0.5 Hz stimulation
(0.858 ± 0.141 vs 0.503 ± 0.077, P < 0.05). The duration of calcium signals
was attenuated in TG mice compared to control at 0.25 Hz (sec, 1.033 ±
0.227 vs 1.507 ± 0.150, P < 0.05)
We conclude that overexpression of annexin VI in mouse myocytes causes
depression in the intracellular free calcium concentration. and frequency-
dependent depression in the extent and rate of the shortening and relength-
ening.
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1766-51 Depressed Intracellular Calcium Homeostasis and
Mechanical Properties of Cardlomyocytes In Annexin
VI Transgenic Mouse
Guojie Song, Ann-Marie E. Gunteski-Hamblin, Gerald W. Darn II, Darryl
L. Kirkpatrick. John R. Dedman, Richard A. Walsh. University of Cincinnah' College of
Medicine, Cincinnati, Ohio
00%
65 (36)
126(29)
80145}
192 (45)
10%
35(19)
112(26)
11%
Acute MI patients (n = 180)
Healthy controls In = 430)
ACE genotype
Conclusion: The approximate allele frequency as well as odds ratio of the
DD genotype is in our study in accordance with other findings (0.53-1.34,
Cambien et ai, Nature 1992;359:641). ACE gene polymorphism is related
to acute MI. its importance in relation to other risk factors needs to be as-
sessed.
circulating ACE activity and to hypertrophic cardiomyopathy. heart failure in
general and maybe also to myocardial infarction (MI). This marker is a dele-
tion (D) or insertion (I) of a gene sequence. This generates three different
genotypes 11.10 and DO.
Aim of study: To prospectively study ACE gene polymorphism in consec-
utive acute MI patients and healthy controls both groups without upper age
limits.
Resu/ts: The genotype frequency is presented in the table. The 0 allele had
approximate frequency of 0.52 in the control group and 0.58 in the acute MI
group. The DO/II ratio was higher in the acute MI group (p < 0.05). Odds ratio
for the DD genotype was 1.35 (confidence interval 0.94--1 .97).
Conclusions:
1. Gene expression can be measured in vivo in endomyocardial biopsies
using RT-OPCA.
2. Using 3-6 endomyocardial biopsies we estimate that mRNA abundance
can be measured for as many as 30 genes of interest.
3. Concentrically hypertrophied myocardium may have a different gene
expression pattern than failing myocardium.
David C. Sane, Nicholaos P. Xenopoulos. Gregory A. Braden. The Bowman Gray
School ofMedicine of Wake Forest University, Winston-Salem, NC
In order to compare the expression of gene products in coronary artery
restenotic (R) lesions versus that in primary atherosclerotic (A) lesions, we
performed RNA fingerprinting of 6 Rand 20 A tissue samples obtained by di-
rectional coronary atherectomy. Poly A+ RNA was extracted and cONA was
produced using AMV reverse transcriptase. Priming was performed using
either oligo dT or an arbitrary primer for first strand synthesis. Arbitrarily-
primed PCR (AP-PCR) amplification of the resultant cDNA was performed
using either a single arbitrary 17-mer or a combination of 2 arbitrary 20-mers
as primers. PCR conditions were adjusted to enhance arbitrary priming and
included a high initial Mg++ concentration (4 mMI, high initial primerconcen-
tration (10 /<.M), and low annealing temperature (40°C). Subsequent cycles
(total of 40) were performed under high stringency conditions and included
10 /<.Ci of dCTP. The PCR products were separated on a 4.5% sequencing
gel and subjected to autoradiography, revealing >50 bands of ",100-500 bp
in size. Two products were expressed at higher levels in R than A samples.
These products were reamplified using the original primers, TA cloned and
sequenced, revealing fibronectin and a unique gene product not found in
GenBank. Our results suggest that: (1). most gene products in R and A sam-
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1766-21 In Vivo Measurement of Myocardial Gene Expression
in the Human Heart
Wayne Minobe, Brian D. Lowes. William 1. Abraham. Arthur M. Feldman, Michael
R. Bristow University of Colorado Health Sciences Center. Denver. Colorado; University
of Pittsburgh Heart Institute, Pittsburgh, Pennsylvania
We have previously described a quantitative method for measuring mRNA
abundance in endomyocardial biopsy-sized pieces of human heart. This
method. reverse transcription-quantitative PCR (RT-OPCRI. uses a known
amount of in vitro transcribed internal standard to generate simultaneously
amplified unknown and standard products in the same amplification reac-
tion. We now describe the use of this method to actually measure mRNA
abundance for genes of interest in endomyocardial biopsy specimens re-
moved from subjects with either idiopathic dilated cardiomyopathy (IDC)
and systolic dysfunction (LVEF = 16.B%, RVEF = 27.7%) or primary pUl-
monary hypertension (PPH) and right ventricular hypertrophy. (Results are
in molecules mRNA x 105//<.g total RNA ± SEM)
